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We report a rare case of aseptic arthritis in the temporomandibular joint of a patient with sickle cell anemia. A 22-
year-old woman with sickle cell disease, in the 18th week of gestation, was referred by her hematologist to investigate a
sudden mouth opening limitation and severe pain on her left cheek. The patient received a standard pain assessment
protocol, clinical examination, and complementary exams (complete blood count, hemoglobin electrophoresis, blood
solubility test, panoramic radiograph, and magnetic resonance imaging [MRI]). The blood results were consistent with a sickle
cell crisis and the MRI showed an inflammatory process around the left temporomandibular joint. Treatment with opioid
analgesics and blood transfusion provided good results. Sickle cell anemia is a disease that can cause arthritis of the
temporomandibular joint, and although it is rare, clinicians should be attentive to the differential diagnosis in patients with
this disease. (Oral Surg Oral Med Oral Pathol Oral Radiol 2013;115:e31-e35)Sickle cell anemia is an autosomal recessive disease
with high prevalence in the world as well as in Brazil (1
in every 200 births)1 and consists of the clinical ex-
pression of a homozygous hemoglobin S gene, where
polymerized hemoglobin leads to chronic hemolytic
anemia.2 It is characterized by vaso-occlusive crises
that affect many organs and manifests primarily by
crises of acute pain.3 The triad of ischemia, infarction,
and inflammation contributes to the pathophysiology of
pain in this condition.4
The interaction between erythrocytes and the vascu-
lar endothelium is critical in the pathogenesis of painful
crises that occur during sickle cell anemia. This process
involves hemoglobin S polymerization, subsequent red
cell distortion, interaction of erythrocytes with adhe-
sion proteins of the vascular endothelium, and an en-
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http://dx.doi.org/10.1016/j.oooo.2012.05.018suing inflammatory response that further increases cel-
lular adhesiveness. In sickle cell disease, erythrocytes
upregulate the expression of intercellular adhesion mol-
ecule-1 and vascular cell adhesion molecule-1 in vas-
cular endothelial cells in vitro. Heme and heme oxy-
genase, the heme-degrading enzyme, are also potent
inducers of inflammation and endothelial cell adhesion,
as is phosphatidylserine when exposed on the surface of
red cells. Increased adhesion and the subsequent in-
flammatory response decrease blood flow, leading to
further sickling in an increasingly hypoxic and acidic
environment. These vaso-occlusive crises are typically
manifested by pain. Repeated episodes of decreased
blood flow can lead to the impaired nourishment of
critical structures (e.g., femoral head, vertebral bodies,
or joint), leading to bony lesions with loss of trabeculae
(e.g., avascular necrosis, vertebral collapse).5-13
Nearly half of sickle cell patients (49%) experience
orofacial pain. Sixty-eight percent experience pulpal
necrosis without apparent cause and 77% experience
headaches.14 Complications such as mandibular osteo-
myelitis and neuropathy, fibrous ankylosis, and asymp-
tomatic pulpal necrosis have been reported.15-18 Limb
joint pain is common, but temporomandibular joint
(TMJ) pain is rare.19 Here, we report a patient who had
aseptic arthritis of the TMJ and sickle cell anemia,
focusing mainly on a multidisciplinary assessment and
the treatment outcome of the patient.
CASE REPORT
A 22-year-old woman in the 18th week of pregnancy was
admitted to the hematology ward after experiencing a throb-
bing pain for 2 days in the left preauricular region. The pain
was constant and severe, scoring 10 on the Visual Analog
e31
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pain increased when she reclined, chewed, or talked and only
subsided with parenteral opioid analgesia. She denied fever or
trauma.
Her medical history at the time of her pregnancy included
various complications associated with sickle cell anemia:
frequent hospitalizations caused by painful crises and epi-
sodes of pneumonia since childhood; ischemic stroke at 10
years old without sequelae; cholecystectomy for cholelithia-
sis; femoral and humeral head osteonecrosis; transfusional
iron overload; and a recent splenic sequestration crisis. Apart
from folic acid supplementation and iron chelation therapy,
she had been treated with hydroxycarbamide for 3 years.
Findings at physical examination included mild edema,
allodynia, and hyperalgesia in the left preauricular region,
hyperalgesia of the left masseter muscle, limited interincisal
mouth opening (11 mm), and pain upon mandibular move-
ment. Only 1 tooth was missing, a maxillary left premolar. No
other dental or periodontal abnormalities were observed dur-
ing the visual examination, with thermal or percussion test-
ing, or on panoramic radiograph (Figure 1).
The following complementary tests were performed: com-
plete blood count, biochemical tests, hemoglobin electropho-
resis (Tables I and II), and magnetic resonance imaging
(MRI; Figure 2). Arthritis in the left condylar head secondary
to a sickle cell crisis was diagnosed after the analysis of the
laboratory tests and images. The final diagnosis rendered was
aseptic arthritis of the left mandibular condyle secondary to a
sickle cell crisis.
Treatment
The patient was admitted to the hematology ward and
Fig. 1. Panoramic radiographs show enlargement of the trabe
apices of the left and right mandibular third molars.received standard analgesia recommended for treatment ofsevere pain: parenteral opioid analgesia and nonsteroidal anti-
inflammatory drugs (NSAIDS; naproxen). She also received a
blood transfusion because of worsening anemia.
The pain gradually subsided after 2 days of hospital stay,
allowing progressive weaning from the analgesic treatment.
Mouth opening amplitude improved substantially to 28 mm
interincisal opening (initially 11 mm). After 1 week, there
was resolution of facial pain and edema; thus, the analgesic
and anti-inflammatory medications were discontinued at this
time. The patient was followed for 6 months without relapse
of facial pain.
DISCUSSION
This rare case of arthritis of the left condylar head
illustrates an uncommon situation of joint pain of sys-
temic origin, although vaso-occlusive crises associated
with sickle cell anemia often cause pain. The pain
lasted 10 days and was accompanied by leukocytosis.
The clinical signs and symptoms were consistent with
the diagnosis of sickle cell crisis.20,21
The patient had a systemic disease that affects bones
and joints, including TMJ. According to the diagnostic
criteria of the American Academy of Orofacial Pain,
the diagnosis requires the presence of a clearly docu-
mented disease or event associated with osteoarthritis,
functional pain, local tenderness, limited TMJ move-
ments and deviation to the affected side, crepitation or
multiple joint noises,22 and manifestations of arthritis
and necrosis in other joints. The present case met all
these criteria. Although the classification of polyarthri-
one in the symphyseal region, bilateral mandibular body, andcular btis does not contemplate sickle cell disease, it should be
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findings have been reported in another case report of a
patient with chronic TMJ pain.23
Of note, in this report the patient was pregnant.
Pregnancy has been shown to worsen sickle cell ane-
mia, increasing its severity and the frequency and se-
verity of pain crises and infection.24 In fact, our patient
had 3 vaso-occlusive crises in the prior 3 months.
Bone and joint areas affected by hypoxia may ini-
tially cause bone hypervascularization and significant
inflammatory processes (osteitis and arthritis), visible
as hyperintensity in MRI in T2 (T2 brightens liquids
and bone edema). Unfortunately, MRI imaging in T2
in this patient could not be fully appreciated and
completed because of the patient’s level of pain.
However, persistent hypoxia and inflammation result
in aseptic bone necrosis, which appears as a hypoin-
tense signal in T2.
Our patient was treated with parenteral opioid anal-
gesia and blood transfusion to prevent progression of
the disease. This treatment reduced pain and improved
joint function, without the need for antibiotics, suggest-
ing that this was probably an acute inflammatory phe-
nomenon with features of aseptic osteonecrosis.
Sickle cell vaso-occlusive episodes require a multi-
disciplinary approach.25 It is important to remember
that these patients have chronic organ damage, such as
Table I. Laboratory data
Variable Reference rang
Hemoglobin (g/dl) 12-16
Hematocrit (%) 35-47
Mean corpuscular volume (mm3) 80-100
White cell count (per mm3) 4,000-11,
Differential count (per mm3)
Neutrophils 1,600-7,0
Lymphocytes 900-3,4
Monocytes 200-900
Eosinophils 50-500
Basophils 0-200
Smear description
Platelet count (per mm3) 140,000-450
Lactate dehydrogenase (U/liter) 240-480
Indirect bilirrubin (mg/dl) 0.10-0.6
Reticulocytes (per mm3) 27,000-134
C-reactive protein (mg/liter) Less than
Table II. Hemoglobin electrophoresisa
Variable Patient (%) Reference range (%)
Hemoglobin S 83.10 0
Hemoglobin A2 2.30 2.0-3.5
Fetal hemoglobin 14.60 Less than 1.2
aElectrophoresis on cellulose acetate, pH 9.1.diastolic dysfunction, that is often unnoticed and thatimproper crisis management may precipitate a serious
acute pulmonary disease (i.e., acute chest syndrome).
Patients are hydrated with dual goals: correct the hy-
povolemia caused by hyposthenuria and insensible
losses and assure intracellular hydration, reducing the
polymerization of desoxihemoglobin S. This aim can
be achieved through hydration with hypotonic saline,
avoiding volume overload that could lead to pulmonary
congestion.26
Pain control is achieved through the judicious use of
analgesics. In inpatients opioid analgesia is recom-
mended, with careful titration of doses to achieve pain
control while avoiding excessive sedation, which could
result in hypoventilation, triggering acute chest syn-
drome. Some patients can be treated with continuous
infusion of morphine using patient-controlled analge-
sia. NSAIDs can be used in the treatment of acute pain
because they inhibit endovascular inflammation by
blocking cyclo-oxygenase. Because the kidney is a
target organ for damage in sickle cell disease, NSAIDs
should be used cautiously and dosage should be re-
stricted. Pain management is often frustrating and
stressful, requiring education of the patient and the
health care team to reduce acute and chronic compli-
cations.26,27
Red blood cell transfusion is recommended when
there is worsening of anemia. Transfusion does not
reduce the duration of existing painful episodes, but can
prevent and treat clinical complications, such as acute
chest syndrome, and restore the proper oxygen trans-
port. Red blood cell transfusion, however, is not innoc-
uous and it is important to remember the acute and
chronic transfusion-related complications such as vol-
ume overload, infections, alloimunization, and iron
s Basal status On admission
9.6 8.3
28.9 24.2
96.3 97.1
14,000 14,700
8,700 9,100
4,300 4,400
800 900
200 300
0 0
Sickled cells
Poikylocytosis
Polycromasia
Sickled cells
Poikylocytosis
Polycromasia
230,000 157,000
571 574
0.68 0.61
208,000 Not available
13.2 34.1e, adult
000
00
00
,000
0
,000overload.28
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aseptic arthritis may occasionally be caused by sickle
cell disease.24 The differential diagnosis should in-
clude avascular necrosis of the condylar head, man-
ifestation of rheumatoid arthritis in the TMJ, and
lupus arthritis of the TMJ.29 Laboratory tests and
diagnostic imaging remain important for proper as-
Fig. 2. Magnetic resonance imaging of the face shows a sign
bone edema (A) with T2 hyperintensity and obliteration of the
pterygoid, also suggesting edema/inflammatory process; B asessment because clinical manifestations of TMJ ar-thritis are similar. Treatment often involves a multi-
disciplinary team and effective communication with
the patient.
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